NewLink Genetics to Webcast 2016 Analyst and Investor Day on October 25, 2016
October 20 2016 - 7:00AM
NewLink Genetics Corporation (NASDAQ:NLNK) today announced
that it will webcast its Analyst and Investor Day being held
on Tuesday, October 25 at the Convene Meeting Center in New
York City.
The Analyst and Investor Day will be webcast live and a link can
be accessed at edge.media-server.com/m/p/8ewqspg8 or through the
NewLink Genetics website, investors.linkp.com/events.cfm, starting
at 12:45 pm ET. The presentation also will be posted to the
Company's website at www.newlinkgenetics.com following
the event.
Institutional investors, portfolio managers or equity research
analysts interested in attending can email
achen@lavoiehealthscience.com to register. Please note that
pre-registration is required to attend.
About NewLink Genetics Corporation
NewLink Genetics is a biopharmaceutical company at the
forefront of discovering, developing and commercializing novel
immuno-oncology product candidates to improve the lives of patients
with cancer. NewLink Genetics' portfolio includes biologic and
small molecule immunotherapy product candidates intended to treat a
wide range of oncology indications. NewLink Genetics' product
candidates are designed to harness multiple components of the
immune system to combat cancer. For more information, please
visit http://www.newlinkgenetics.com.
Cautionary Note Regarding Forward-Looking
Statements
This press release contains forward-looking statements
of NewLink Genetics that involve substantial risks and
uncertainties. All statements, other than statements of historical
facts, contained in this press release are forward-looking
statements, within the meaning of The Private Securities Litigation
Reform Act of 1995. The words "anticipate," "believe," "estimate,"
"expect," "intend," "may," "plan," "target," "potential," "will,"
"could," "should," "seek" or the negative of these terms or other
similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain
these identifying words. These forward-looking statements include
any statements other than statements of historical fact. Actual
results or events could differ materially from the plans,
intentions and expectations disclosed in the forward-looking
statements that NewLink Genetics makes due to a number of
important factors, including those risks discussed in "Risk
Factors" and elsewhere in NewLink Genetics' Annual Report on Form
10-K for the year ended December 31, 2015 and other
reports filed with the U.S. Securities and Exchange
Commission (SEC). The forward-looking statements in this press
release represent NewLink' Genetics' views as of the date of this
press release. NewLink Genetics anticipates that
subsequent events and developments will cause its views to change.
However, while it may elect to update these forward-looking
statements at some point in the future, it specifically disclaims
any obligation to do so. You should, therefore, not rely on these
forward-looking statements as representing NewLink Genetics' views
as of any date subsequent to the date of this press release.
Corporate Contact:Jack HennemanChief Financial Officer(515)
598-2561Investor@linkp.com
Media and Investor Contacts:MediaBen
NavonLaVoieHealthScience617-374-8800, ext.
108bnavon@lavoiehealthscience.com
InvestorsBeth KurthLaVoieHealthScience617-374-8800, ext.
106bkurth@lavoiehealthscience.com
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From Mar 2024 to Apr 2024
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From Apr 2023 to Apr 2024